{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:10:51Z","timestamp":1764738651305,"version":"3.46.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"RA MES Higher Education and Science Committee","award":["21T-3C166"],"award-info":[{"award-number":["21T-3C166"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11064-025-04592-8","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:00:34Z","timestamp":1761811234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Amyloid Toxicity: Novel Cholinesterase Inhibitors Protect Hippocampal Cells from Amyloid Peptide-Derived Death"],"prefix":"10.1007","volume":"50","author":[{"given":"Sona","family":"Buloyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anahit","family":"Poghosyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayk","family":"Harutyunyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermine","family":"Yeritsyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Sargsyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armen","family":"Hovhannisyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vigen","family":"Topuzyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hrachik","family":"Gasparyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"4592_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1006\/jmbi.1997.1245","volume":"272","author":"A Alvarez","year":"1997","unstructured":"Alvarez A, Opazo C, Alarcon R, Garrido J, Inestrosa NC (1997) Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. J Mol Biol 272:348\u2013361. https:\/\/doi.org\/10.1006\/jmbi.1997.1245","journal-title":"J Mol Biol"},{"issue":"6","key":"4592_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0301-0082(98)00022-7","volume":"55","author":"BH Anderton","year":"1998","unstructured":"Anderton BH, Callahan L, Coleman P, Davies P, Flood D, Jicha GA, Ohm T, Weaver C (1998) Dendritic changes in Alzheimer\u2019s disease and factors that may underline, these changes. Prog Neurobiol 55(6):595\u2013609. https:\/\/doi.org\/10.1016\/S0301-0082(98)00022-7","journal-title":"Prog Neurobiol"},{"key":"4592_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/CON.0000000000000307","volume":"22","author":"LG Apostolova","year":"2016","unstructured":"Apostolova LG (2016) Alzheimer Disease. Continuum (Minneap Minn) 22:419\u2013434. https:\/\/doi.org\/10.1212\/CON.0000000000000307","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"4592_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0028-3908(03)00317-4","volume":"46","author":"E Arias","year":"2004","unstructured":"Arias E, Al\u00e9s E, Gabilan NH, Cano-Abad MF, Villarroya M, Garc\u00eda AG, L\u00f3pez MG (2004) Galantamine prevents apoptosis induced by \u03b2-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology 46(1):103\u2013114. https:\/\/doi.org\/10.1016\/s0028-3908(03)00317-4","journal-title":"Neuropharmacology"},{"key":"4592_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1471-4159.1986.tb02858.x","volume":"47","author":"JR Atack","year":"1986","unstructured":"Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH (1986) Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochem 47:263\u2013277. https:\/\/doi.org\/10.1111\/j.1471-4159.1986.tb02858.x","journal-title":"J Neurochem"},{"key":"4592_CR6","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1523\/jneurpsci.14-05-02476","volume":"14","author":"I Aubert","year":"1994","unstructured":"Aubert I, Poirier J, Gauthier S, Quirion R (1994) Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions. J Neurosci 14:2476\u20132484. https:\/\/doi.org\/10.1523\/jneurpsci.14-05-02476","journal-title":"J Neurosci"},{"key":"4592_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408\u2013414. https:\/\/doi.org\/10.1126\/science.7046051","journal-title":"Science"},{"issue":"3","key":"4592_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005593","volume":"2016","author":"J Birks","year":"2006","unstructured":"Birks J (2006) Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst Rev CD005593. https:\/\/doi.org\/10.1002\/14651858.CD005593","journal-title":"Cochrane Database Syst Rev"},{"key":"4592_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0165-0270(96)00136-7","volume":"71","author":"GJ Brewer","year":"1997","unstructured":"Brewer GJ (1997) Isolation and culture of adult rat hippocampal neurons. J Neurosci Methods 71:143\u2013155. https:\/\/doi.org\/10.1016\/S0165-0270(96)00136-7","journal-title":"J Neurosci Methods"},{"key":"4592_CR10","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1007\/s11064-007-9567-7","volume":"33","author":"GV Chaitanya","year":"2008","unstructured":"Chaitanya GV, Babu PP (2008) Activation of calpain, cathepsin-b and caspase-3 during transient focal cerebral ischemia in rat model. Neurochem Res 33:2178\u20132186. https:\/\/doi.org\/10.1007\/s11064-007-9567-7","journal-title":"Neurochem Res"},{"key":"4592_CR11","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.6338589","volume":"219","author":"JT Coyle","year":"1983","unstructured":"Coyle JT, Price DL, DeLong MR (1983) Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation. Science 219:1184\u20131190. https:\/\/doi.org\/10.1126\/science.6338589","journal-title":"Science"},{"issue":"1","key":"4592_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/156720510790274455","volume":"7","author":"T Darreh-Shori","year":"2010","unstructured":"Darreh-Shori T, Soininen H (2010) Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with alzheimer\u2019s disease: a review of recent clinical studies. Curr Alzheimer Res 7(1):67\u201373. https:\/\/doi.org\/10.2174\/156720510790274455","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"4592_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00862-1","volume":"27","author":"BL Gao","year":"2022","unstructured":"Gao BL, Che NN, Li X, Ren CF (2022) Neuroprotective effects of donepezil against A\u03b225-35-induced neurotoxicity. Eur J Med Res 27(1):219. https:\/\/doi.org\/10.1186\/s40001-022-00862-1","journal-title":"Eur J Med Res"},{"key":"4592_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3897\/rrpharmacology.8.87431","volume":"8","author":"HV Gasparyan","year":"2022","unstructured":"Gasparyan HV, Buloyan SA, Harutyunyan HA, Pogosyan AE, Arshakyan LM, Harutyunyan LS, Avetisyan ZA, Tosunyan SR, Hovhannisyan AA, Topuzyan VO (2022) Study of neuroprotective activity of new acetylcholinesterase inhibitors TVA and TVS in experimental model of alzhemer\u2019s disease. Res Results Pharmacol 8:77\u201388. https:\/\/doi.org\/10.3897\/rrpharmacology.8.87431","journal-title":"Res Results Pharmacol"},{"issue":"4","key":"4592_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","volume":"50","author":"E Giacobini","year":"2004","unstructured":"Giacobini E (2004) Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol Res 50(4):433. https:\/\/doi.org\/10.1016\/j.phrs.2003.11.017","journal-title":"Pharmacol Res"},{"key":"4592_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.14283\/jpad.2018.43","volume":"6","author":"H Hampel","year":"2019","unstructured":"Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Vergallo A, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS (2019) Revisiting the cholinergic hypothesis in alzheimer\u2019s disease: emerging evidence from translational and clinical research. J Prev Alzheimer\u2019s Dis 6:2\u201315. https:\/\/doi.org\/10.14283\/jpad.2018.43","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"4592_CR17","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1038\/s41598-022-06637-2","volume":"12","author":"ER Hascup","year":"2022","unstructured":"Hascup ER, Sime LN, Peck MR, Hascup KN (2022) Amyloid-\u03b242 stimulated hippocampal lactate release is coupled to glutamate uptake. Sci Rep 12:2775. https:\/\/doi.org\/10.1038\/s41598-022-06637-2","journal-title":"Sci Rep"},{"key":"4592_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9:119\u2013128. https:\/\/doi.org\/10.1016\/S1474-4422(09)70299-6","journal-title":"Lancet Neurol"},{"key":"4592_CR19","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.1074\/jbc.RA118.006230","volume":"294","author":"L Jean","year":"2019","unstructured":"Jean L, Brimijoin S, Vaux DJ (2019) In vivo localization of human acetylcholinesterase-derived species in a \u03b2-sheet conformation at the core of senile plaques in Alzheimer\u2019s disease. J Biol Chem 294:6253\u20136272. https:\/\/doi.org\/10.1074\/jbc.RA118.006230","journal-title":"J Biol Chem"},{"key":"4592_CR20","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1073\/pnas.76.10.5392","volume":"76","author":"MV Johnston","year":"1979","unstructured":"Johnston MV, McKinney M, Coyle JT (1979) Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Proc Natl Acad Sci USA 76:5392\u20135396. https:\/\/doi.org\/10.1073\/pnas.76.10.5392","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4592_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.brainres.2005.04.014","volume":"1047","author":"M Kimura","year":"2005","unstructured":"Kimura M, Akasofu S, Ogura H, Sawada K (2005) Protective effect of donepezil against Abeta(1\u201340) neurotoxicity in rat septal neurons. Brain Res 1047(1):72\u201384. https:\/\/doi.org\/10.1016\/j.brainres.2005.04.014","journal-title":"Brain Res"},{"key":"4592_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/S14611457","volume":"9","author":"RM Lane","year":"2006","unstructured":"Lane RM, Potkin SG, Enz A (2006) Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol 9:101\u2013124. https:\/\/doi.org\/10.1017\/S14611457","journal-title":"Int J Neuropsychopharmacol"},{"key":"4592_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0379-4","volume":"12","author":"YH Liu","year":"2015","unstructured":"Liu YH, Bu XL, Liang CR, Wang YR, Zhang T, Jiao SS, Zeng F, Yao XQ, Zhou HD, Deng J (2015) An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect. J Neuroinflammation 12:1\u20138. https:\/\/doi.org\/10.1186\/s12974-015-0379-4","journal-title":"J Neuroinflammation"},{"key":"4592_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0063-8","volume":"4","author":"PP Liu","year":"2019","unstructured":"Liu PP, Xie Y, Meng XY, Kang JS (2019) History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal Transduct Target Ther 4:29. https:\/\/doi.org\/10.1038\/s41392-019-0063-8","journal-title":"Signal Transduct Target Ther"},{"key":"4592_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jare.2021.05.007","volume":"36","author":"KJY Low","year":"2022","unstructured":"Low KJY, Venkatraman A, Mehta JS, Pervushin K (2022) Molecular mechanisms of amyloid disaggregation. J Adv Res 36:113\u2013132. https:\/\/doi.org\/10.1016\/j.jare.2021.05.007","journal-title":"J Adv Res"},{"issue":"23","key":"4592_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cmet.2015.10.010","volume":"12","author":"P Machler","year":"2016","unstructured":"Machler P, Wyss MT, Elsayed M, Stobart J, Gutierrez R, Faber-Castell A, Kaelin V, Zuend M, San Martin A et al (2016) In vivo evidence for a lactate gradient from astrocytes to neurons. Cell. Metab. 12(23):94\u2013102. https:\/\/doi.org\/10.1016\/j.cmet.2015.10.010","journal-title":"Cell. Metab."},{"key":"4592_CR27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1134\/S1819712423040177","volume":"17","author":"SS Mardanyan","year":"2023","unstructured":"Mardanyan SS, Karapetyan LG, Antonyan AA, Sharoyan SG, Gasparyan HV, Buloyan S, Harutyunyan HA, Pogosyan AE, Arshakyan L, Hovhanesyan AA, Topuzyan VO (2023) Optical characteristics and neuroprotective properties of \u03b2-dimethylaminoethylamide N-benzoyl-DL-valine iodmethylate and 1-( \u03b2-diethylaminoethyl)-2-. Neurochem J 17:668\u2013675. phenyl-4-benzylidene-5-imidazolone https:\/\/doi.org\/10.1134\/S1819712423040177","journal-title":"Neurochem J"},{"issue":"4","key":"4592_CR28","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.bbadis.2016.01.013","volume":"1862","author":"LA Mohamed","year":"2016","unstructured":"Mohamed LA, Keller JN, Kaddoumi A (2016) Role of P-glycoprotein in mediating Rivastigmine effect on amyloid-\u03b2 brain load and related pathology in alzheimer\u2019s disease mouse model. Biochim Biophys Acta 1862(4):778\u2013787. https:\/\/doi.org\/10.1016\/j.bbadis.2016.01.013","journal-title":"Biochim Biophys Acta"},{"key":"4592_CR29","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","volume":"8","author":"EJ Mufson","year":"2008","unstructured":"Mufson EJ, Counts SE, Perez SE, Ginsberg SD (2008) Cholinergic system during the progression of Alzheimer\u2019s disease: therapeutic implications. Expert Rev Neurother 8:1703\u20131718. https:\/\/doi.org\/10.1586\/14737175.8.11.1703","journal-title":"Expert Rev Neurother"},{"key":"4592_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0014-5793(99)00468-8","volume":"450","author":"FJ Munoz","year":"1999","unstructured":"Munoz FJ, Inestrosa NC (1999) Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the ache concentration present in the complexes. FEBS Lett 450:205\u2013209. https:\/\/doi.org\/10.1016\/S0014-5793(99)00468-8","journal-title":"FEBS Lett"},{"key":"4592_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0140-6736(91)93391-L","volume":"337","author":"DS Navaratnam","year":"1991","unstructured":"Navaratnam DS, Priddle JD, McDonald B, Esiri MM, Robinson JR, Smith AD (1991) Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer\u2019s disease. Lancet 337:447\u2013450. https:\/\/doi.org\/10.1016\/0140-6736(91)93391-L","journal-title":"Lancet"},{"key":"4592_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2144\/btn-2022-0064","volume":"73","author":"J Nilles","year":"2022","unstructured":"Nilles J, Weiss J, Theile D (2022) Crystal Violet staining is reliable alternative to bicinchoninic acid assay-based normalization. Biotechniques 73:131\u2013135. https:\/\/doi.org\/10.2144\/btn-2022-0064","journal-title":"Biotechniques"},{"key":"4592_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.etap.2004.12.048","volume":"19","author":"C Pape","year":"2005","unstructured":"Pape C, Karanth S, Liu Jing (2005) Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action. Environ Toxicol Pharmacol 19:433\u2013446. https:\/\/doi.org\/10.1016\/j.etap.2004.12.048","journal-title":"Environ Toxicol Pharmacol"},{"key":"4592_CR34","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/jcbfm.2011.149","volume":"32","author":"L Pellerin","year":"2012","unstructured":"Pellerin L, Magistretti PJ (2012) Sweet sixteen for ANLS. J Cereb Blood Flow Metab 32:1152\u20131166. https:\/\/doi.org\/10.1038\/jcbfm.2011.149","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"4592_CR35","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1021\/cr00081a005","volume":"87","author":"DM Quinn","year":"1987","unstructured":"Quinn DM (1987) Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem Rev 87(5):955\u2013979. https:\/\/doi.org\/10.1021\/cr00081a005","journal-title":"Chem Rev"},{"key":"4592_CR36","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0002-9440(10)63774-1","volume":"164","author":"AE Reyes","year":"2004","unstructured":"Reyes AE, Chac\u00f3n MA, Dinamarca MC, Cerpa W, Morgan C, Inestrosa NC (2004) Acetylcholinesterase-A\u03b2 complexes are more toxic than A\u03b2 fibrils in rat hippocampus: effect on rat \u03b2-Amyloid Aggregation, laminin Expression, reactive Astrocytosis, and neuronal cell loss. Am J Pathol 164:2163\u20132174. https:\/\/doi.org\/10.1016\/S0002-9440(10)63774-1","journal-title":"Am J Pathol"},{"issue":"9082","key":"4592_CR37","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(97)24039-0","volume":"350","author":"J Saez-Valero","year":"1997","unstructured":"Saez-Valero J, Sberna G, McLean CA, Masters CL, Small DH (1997) Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer\u2019s disease. Lancet 350:929. https:\/\/doi.org\/10.1016\/S0140-6736(97)24039-0","journal-title":"Lancet"},{"key":"4592_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0006-8993(02)04159-8","volume":"965","author":"J Saez-Valero","year":"2003","unstructured":"Saez-Valero J, Fodero LR, White AR, Barrow CJ, Small DH (2003) Acetylcholinesterase is increased in mouse neuronal and astrocyte cultures after treatment with \u03b2-amyloid peptides. Brain Res 965:283\u2013286. https:\/\/doi.org\/10.1016\/S0006-8993(02)04159-8","journal-title":"Brain Res"},{"key":"4592_CR39","doi-asserted-by":"publisher","DOI":"10.1042\/NS20180207","author":"MP Sahu","year":"2019","unstructured":"Sahu MP, Nikkil\u00e4 O, L\u00e5gas S, Kolehmainen S, Castr\u00e9n E (2019) Culturing primary neurons from rat hippocampus and cortex. Neuronal Signal. https:\/\/doi.org\/10.1042\/NS20180207","journal-title":"Neuronal Signal"},{"key":"4592_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0197-0186(95)00099-2","volume":"28","author":"DH Small","year":"1996","unstructured":"Small DH, Michaelson S, Sberna G (1996) Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer\u2019s disease. Neurochem Int 28:453\u2013483. https:\/\/doi.org\/10.1016\/0197-0186(95)00099-2","journal-title":"Neurochem Int"},{"issue":"3","key":"4592_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/0929867003375191","volume":"7","author":"H Sugimoto","year":"2000","unstructured":"Sugimoto H, Yamanishi Y, Iimura Y, Kawakami Y (2000) Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors. Curr Med Chem 7(3):303\u2013339. https:\/\/doi.org\/10.2174\/0929867003375191","journal-title":"Curr Med Chem"},{"issue":"51","key":"4592_CR42","doi-asserted-by":"publisher","first-page":"40180","DOI":"10.1074\/jbc.M110.142356","volume":"285","author":"K Takata","year":"2010","unstructured":"Takata K, Kitamura Y, Saeki M, Terada M, Kagitani S, Kitamura R, Fujikawa Y, Maelicke A, Tomimoto H, Taniguchi T, Shimohama S (2010) Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. J Biol Chem 285(51):40180\u201340191. https:\/\/doi.org\/10.1074\/jbc.M110.142356","journal-title":"J Biol Chem"},{"key":"4592_CR43","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0047-6374(01)00309-8","volume":"122","author":"VN Talesa","year":"2001","unstructured":"Talesa VN (2001) Acetylcholinesterase in Alzheimer\u2019s disease. Mech Ageing Dev 122:1961\u20131969. https:\/\/doi.org\/10.1016\/S0047-6374(01)00309-8","journal-title":"Mech Ageing Dev"},{"key":"4592_CR44","first-page":"268","volume":"118","author":"VO Topuzyan","year":"2018","unstructured":"Topuzyan VO, Ghazoyan VM (2018) 2,4-Disubstituted 5(4H)-imidazolones: new class of cholinesterase inhibitors. Reports of NAS RA. Bioorg Chem 118:268\u2013272 Doi.547.787","journal-title":"Bioorg Chem"},{"key":"4592_CR45","volume-title":"N-benzoyl-DL-valine 2-(dimethyl)ethylamide iodometilate with high selectivity toward butyrylcholinesterase. (AM Patent No. 2696 A)","author":"V Topuzyan","year":"2012","unstructured":"Topuzyan V, Halebyan K, Karapetyan I (2012) N-benzoyl-DL-valine 2-(dimethyl)ethylamide iodometilate with high selectivity toward butyrylcholinesterase. (AM Patent No. 2696 A). Intellectual Property Agency of RA"},{"key":"4592_CR46","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1134\/S1070428018090178","volume":"54","author":"VO Topuzyan","year":"2018","unstructured":"Topuzyan VO, Kazoyan VM, Tamazyan RA, Aivazyan AG, Galstyan LK (2018) Synthesis and anticholinesterase activity of [(4Z)-2-aryl-4-(arylmethylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl] alkanoicacids. Russ J Org Chem 54:1369\u20131377. https:\/\/doi.org\/10.1134\/S1070428018090178","journal-title":"Russ J Org Chem"},{"key":"4592_CR47","first-page":"162","volume":"119","author":"VO Topuzyan","year":"2019","unstructured":"Topuzyan VO, Hovhannisyan AA, Ghazoyan VM, Alexanyan ER (2019) Synthesis and anticholinesterase properties of (Z)-1-substituted-2-phenyl-4-(p-toluolphoeniloxibenzilidene)-5-imidazolones. Reports of NAS RA. Bioorg Chem 119:162\u2013170","journal-title":"Bioorg Chem"},{"key":"4592_CR48","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1134\/S1070363222090043","volume":"92","author":"V Topuzyan","year":"2022","unstructured":"Topuzyan V, Hovhannisyan A, Tosunyan S, Tamazyan R, Ayvazyan A, Makichyan A (2022) Synthesis and anticholinesterase activity of 4-arylidene-1-[\u03c9-(dialkylamino)alkyl]-2-phenyl-4,5-dihydro-1(H)-imidazole-5-ones. Russ J Gen Chem 92:1610\u20131620. https:\/\/doi.org\/10.1134\/S1070363222090043","journal-title":"Russ J Gen Chem"},{"key":"4592_CR49","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/clinchem\/18.11.1334","volume":"18","author":"JO Westgard","year":"1972","unstructured":"Westgard JO, Lahmeyer BL, Birnbaum ML (1972) Use of the du Pont \u2018automatic clinical analyzer\u2019 in direct determination of lactic acid in plasma stabilized with sodium fluoride. Clin Chem 18:1334\u20131338","journal-title":"Clin Chem"},{"key":"4592_CR50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1126\/science.2218531","volume":"250","author":"BA Yankner","year":"1990","unstructured":"Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid \u03b2 protein: reversal by tachykinin neuropeptides. Science 250:279\u2013282. https:\/\/doi.org\/10.1126\/science.2218531","journal-title":"Science"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04592-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04592-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04592-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:06:34Z","timestamp":1764738394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04592-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4592"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04592-8","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"type":"print","value":"0364-3190"},{"type":"electronic","value":"1573-6903"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"338"}}